Higher prevalence of urogenital mycoplasmas in human immunodeficiency virus-positive patients as compared to patients with other sexually transmitted diseases

被引:0
|
作者
Cordova, CMM
Blanchard, A
Cunha, RAF
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Lab Imunol Clin, BR-05508900 Sao Paulo, Brazil
[2] Inst Pasteur, Unite Oncol Virale, F-75724 Paris, France
关键词
Mycoplasma genitalium; M; fermentans; penetrans; HIV; STD; nongonococcal urethritis (NGU); PCR;
D O I
10.1002/1098-2825(2000)14:5<246::AID-JCLA8>3.0.CO;2-F
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We determined the prevalence of three emergent urogenital mycoplasma species (M. fermentans, M. penetrans, and M. genitalium) in comparison to the most common species (RI. hominis and U. urealyticum). M. genitalium is probably the third most frequent agent of nongonococcal urethritis (NGU) in men. It has been suggested that M. fermentans and M. penetrans play a role in the development of AIDS. We analysed the urine and the urethral swab samples from 106 HIV-1 infected individuals (HIV group) and 110 HIV-negative patients with NGU (STD group) by using PCR and culture methods. M. genitalium was detected in 0.9% of the urine and in 1.9% of the urethral samples from the HIV group, compared to 9.1% found only in urethral swab samples from the STD group. M. fermentans was detected in 5.7% urethral swabs from the HIV group and in 0.9% from the STD group. M. penetrans was detected in 6.6% urine samples from the HIV group. M. hominis and U. urealyticum showed infection rates of 7.5 and 18.9% in the HIV group, and 0.9 and 13.6% in the STD group. Overall there was a higher prevalence of mycoplasmas in the HIV group than in the STD group, but the significance of these results remains unclear. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [12] Sexually transmitted infections and cervicovaginal dysplasia in a cohort of human immunodeficiency virus-positive women in Turin
    Pugliese, A
    Saini, A
    Andronico, L
    Pagliano, G
    Gallo, G
    CANCER DETECTION AND PREVENTION, 2001, 25 (01): : 32 - 39
  • [13] Heart Transplantation in Human Immunodeficiency Virus-Positive Patients
    Uriel, Nir
    Jorde, Ulrich P.
    Cotarlan, Vlad
    Colombo, Paolo C.
    Farr, Maryjane
    Restaino, Susan W.
    Lietz, Katherine
    Naka, Yoshifuma
    Deng, Mario C.
    Mancini, Donna
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (07): : 667 - 669
  • [14] Hydroxyurea toxicity in human immunodeficiency virus-positive patients
    Goodrich, J
    Khardori, N
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) : 692 - 693
  • [15] Hepatic hydatidosis in human immunodeficiency virus-positive patients
    Manuel-Vazquez, Alba
    Latorre-Fragua, Raquel
    Espinosa, Alfredo
    del Cerro, Julian
    Manuel Ramia, Jose
    CIRUGIA ESPANOLA, 2019, 97 (04): : 239 - 241
  • [16] Liver Transplantation in Human Immunodeficiency Virus-Positive Patients
    Joshi, Deepak
    O'Grady, John
    Taylor, Chris
    Heaton, Nigel
    Agarwal, Kosh
    LIVER TRANSPLANTATION, 2011, 17 (08) : 881 - 890
  • [17] INCREASING PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AMONG PATIENTS ATTENDING A CLINIC FOR SEXUALLY-TRANSMITTED DISEASES
    JACOB, M
    JOHN, TJ
    GEORGE, S
    RAO, PSS
    BABU, PG
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1995, 101 : 6 - 9
  • [18] Sexually transmitted diseases other than human immunodeficiency virus infection in older adults
    Calvet, HM
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 609 - 614
  • [19] Characteristics of Aneurysmal Disease in Human Immunodeficiency Virus-Positive Patients
    Kim, Tanner
    Hessel, Kara
    Orion, Kristine
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (01) : E130 - E131
  • [20] Treatment of depressive symptoms in human immunodeficiency virus-positive patients
    Markowitz, JC
    Kocsis, JH
    Fishman, B
    Spielman, LA
    Jacobsberg, LB
    Frances, AJ
    Klerman, GL
    Perry, SW
    ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (05) : 452 - 457